1200 Pharma

1200 Pharma LLC is a privately held pre-clinical drug discovery company founded in 2017 and headquartered in Culver City, California, with roots in Pasadena. It was launched by Caltech chemist Brian Stoltz, UCLA translational oncologist Dennis Slamon and chief executive David Licata, and it pairs Caltech medicinal-chemistry methodology with UCLA biomarker-driven screening assays to identify novel small-molecule oncology candidates — including KRAS and CDK inhibitors — at a fraction of the industry-average cost and timeline. The company employs roughly 20-50 people, has filed patents covering indole-based anti-cancer compounds, and has raised approximately $14.1 million from Kairos Ventures, Vest Coast Capital, OCV Partners, Alexandria Venture Investments, Pasadena Bio and the National Institutes of Health. Its product is drug intellectual property and discovery partnerships, not software: no developer program, public API, SDK, developer portal or machine-readable contract of any kind could be found, and no api/docs/developer hostname exists under its domain. At the time of profiling its only web property, 1200pharma.com, was not being served — the Cloudflare edge in front of it terminated every TLS handshake and answered plain HTTP with error 1001 — so the corporate site itself could not be read.

1200 Pharma is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Medicinal Chemistry.

3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-09-25 · rubric v0.23.0
0 APIs
CompanyBiotechnologyPharmaceuticalsDrug DiscoveryMedicinal ChemistryOncologySmall MoleculeLife SciencesHealthcareUnited States

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-25 · rubric v0.23.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/1200pharma: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

1200Pharma Domain Security

no transport/DNS hardening detected

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: 1200pharma
name: 1200 Pharma
description: '1200 Pharma LLC is a privately held pre-clinical drug discovery company founded in 2017 and headquartered in
  Culver City, California, with roots in Pasadena. It was launched by Caltech chemist Brian Stoltz, UCLA translational oncologist
  Dennis Slamon and chief executive David Licata, and it pairs Caltech medicinal-chemistry methodology with UCLA biomarker-driven
  screening assays to identify novel small-molecule oncology candidates — including KRAS and CDK inhibitors — at a fraction
  of the industry-average cost and timeline. The company employs roughly 20-50 people, has filed patents covering indole-based
  anti-cancer compounds, and has raised approximately $14.1 million from Kairos Ventures, Vest Coast Capital, OCV Partners,
  Alexandria Venture Investments, Pasadena Bio and the National Institutes of Health. Its product is drug intellectual property
  and discovery partnerships, not software: no developer program, public API, SDK, developer portal or machine-readable contract
  of any kind could be found, and no api/docs/developer hostname exists under its domain. At the time of profiling its only
  web property, 1200pharma.com, was not being served — the Cloudflare edge in front of it terminated every TLS handshake and
  answered plain HTTP with error 1001 — so the corporate site itself could not be read.'
url: https://raw.githubusercontent.com/api-evangelist/1200pharma/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-harvest-source-url: https://equityzen.com/company/1200pharma
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-05'
modified: '2026-09-05'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Medicinal Chemistry
- Oncology
- Small Molecule
- Life Sciences
- Healthcare
- United States
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/1200pharma-domain-security.yml
- type: Website
  url: https://1200pharma.com/
x-enrichment:
  date: '2026-09-05'
  status: minimal
  artifacts_added: 2
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: '1200 Pharma is a pre-clinical small-molecule oncology discovery lab whose product is drug IP and partnerships rather
    than software — no GitHub organization exists, no package is published to npm or PyPI, and api/docs/developer/portal/app/data/platform
    hostnames all return NXDOMAIN under its domain — and its one web property, 1200pharma.com, could not be read at all because
    the Cloudflare edge in front of it terminates every TLS handshake with alert 40 before presenting a certificate (reproduced
    independently from a third-party headless-browser egress) and answers plain HTTP on every path with 409 Conflict / "error
    code: 1001".'
  evidence:
  - url: https://1200pharma.com/
    status: 0
  - url: http://1200pharma.com/
    status: 409
  - url: http://1200pharma.com/.well-known/security.txt
    status: 409
  - url: https://api.github.com/search/users?q=1200pharma
    status: 200
  checked: '2026-09-05'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/1200pharma"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/1200pharma/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/1200pharma/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.